These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7684013)

  • 1. Cyclic neutropenia and severe hypogammaglobulinemia in a patient with excess of CD8-positive T lymphocytes: response to G-CSF therapy.
    Ferrero D; Pregno P; Omedè P; Dianzani U; Carbone A; di Celle PF; Gallo E
    Haematologica; 1993; 78(1):49-52. PubMed ID: 7684013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient cyclic neutropenia following GM-CSF in a patient with chronic granulocytic leukemia transplanted with HLA-identical T cell-depleted donor bone marrow.
    Gluckman E; Socie G; Yver A; Esperou H; Devergie A; Stern A
    Bone Marrow Transplant; 1989 Sep; 4(5):591-2. PubMed ID: 2676045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hematopoietic growth factors in patients receiving intensive chemotherapy for malignant disorders: studies of granulocyte-colony stimulating factor (G-CSF), granulocyte-macrophage colony stimulating factor (GM-CSF), interleukin-3 (IL-3) and Flt-3 ligand (Flt3L).
    Bruserud O; Foss B; Petersen H
    Eur Cytokine Netw; 2001; 12(2):231-8. PubMed ID: 11399510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [rhG-CSF treatment in cyclic neutropenia. Continuous versus intermittent rhG-CSF treatment in cyclic neutropenia].
    Nielsen H; Hansen PB
    Ugeskr Laeger; 1994 Jan; 156(3):324-5. PubMed ID: 8296427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-CSF in the long-term treatment of cyclic neutropenia and chronic idiopathic neutropenia in adult patients.
    Heussner P; Haase D; Kanz L; Fonatsch C; Welte K; Freund M
    Int J Hematol; 1995 Dec; 62(4):225-34. PubMed ID: 8589368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical use of granulocyte colony stimulating-factors (GM-CSF and G-CSF].
    Borota R; Borota J; Belić A; Gebauer E; Stefanović N
    Med Pregl; 1997; 50(3-4):87-93. PubMed ID: 9229690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Granulocyte colony-stimulating factor in neutropenia secondary to lymphoid bone marrow infiltration].
    Hammerstrøm J
    Tidsskr Nor Laegeforen; 1996 Feb; 116(4):484-6. PubMed ID: 8644050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correction of neutropenia and hypogammaglobulinemia in X-linked hyper-IgM syndrome by allogeneic bone marrow transplantation.
    Scholl PR; O'Gorman MR; Pachman LM; Haut P; Kletzel M
    Bone Marrow Transplant; 1998 Dec; 22(12):1215-8. PubMed ID: 9894727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Additive effects of infection and neutropenia on the induction of granulocytopoietic activity in vivo.
    Bönig HB; Hannen M; Lex C; Wölfel S; Banning U; Nürnberger W; Körholz D; Göbel U
    Cancer; 1999 Jul; 86(2):340-8. PubMed ID: 10421271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro sensitivity of post-bone marrow transplantation CFU-GM and BFU-E to TNF-alpha and IFN-gamma.
    Papadakis V; Ferguson KF; Heller G; Kernan NA
    Exp Hematol; 1995 Dec; 23(14):1422-30. PubMed ID: 8542927
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of the efficacy and tolerability of recombinant haematopoietic growth factors in bone marrow transplantation.
    Barge AJ
    Bone Marrow Transplant; 1993; 11 Suppl 2():1-11. PubMed ID: 8334433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malignant myeloid transformation in congenital forms of neutropenia.
    Freedman MH; Alter BP
    Isr Med Assoc J; 2002 Nov; 4(11):1011-4. PubMed ID: 12489493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential immunostimulating effect of granulocyte-macrophage colony-stimulating factor (GM-CSF), granulocyte colony-stimulating factor (G-CSF) and interferon gamma (IFNgamma) after severe trauma.
    Lendemans S; Kreuzfelder E; Waydhas C; Schade FU; Flohé S
    Inflamm Res; 2007 Jan; 56(1):38-44. PubMed ID: 17334669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.
    Rutella S; Pierelli L; Sica S; Serafini R; Chiusolo P; Paladini U; Leone F; Zini G; D'Onofrio G; Leone G; Piccirillo N
    Cytotherapy; 2003; 5(1):19-30. PubMed ID: 12745586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Special Education: Aplastic Anemia.
    Teramura M; Mizoguchi H
    Oncologist; 1996; 1(3):187-189. PubMed ID: 10387986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-macrophage colony-stimulating factor (GM-CSF) restores decreased monocyte HLA-DR expression after cardiopulmonary bypass.
    Börgermann J; Friedrich I; Scheubel R; Kuss O; Lendemans S; Silber RE; Kreuzfelder E; Flohé S
    Thorac Cardiovasc Surg; 2007 Feb; 55(1):24-31. PubMed ID: 17285470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [T-cell granular lymphocyte-proliferative disorder without severe infection for 13 years despite severe neutropenia].
    Tanaka H; Hashimoto S; Sakai C; Abe D; Sakai S; Takagi T
    Rinsho Ketsueki; 2010 Feb; 51(2):143-7. PubMed ID: 20379107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy.
    Wong SF; Chan HO
    Pharmacotherapy; 2005 Mar; 25(3):372-8. PubMed ID: 15843284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.